vasculitis
Information
- Disease name
- vasculitis
- Disease ID
- DOID:865
- Description
- "A vascular disease that is characterized by inflammation of the blood vessels." [url:http\://en.wikipedia.org/wiki/Vasculitis, url:http\://www.nhlbi.nih.gov/health/health-topics/topics/vas/, url:http\://www.nlm.nih.gov/medlineplus/vasculitis.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06266247 | Active, not recruiting | N/A | How Sirtuin Levels Change During Behçet Disease | January 15, 2024 | October 30, 2024 |
| NCT01933724 | Active, not recruiting | Phase 3 | The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric Approach | February 17, 2014 | December 31, 2023 |
| NCT03755245 | Active, not recruiting | N/A | Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis | November 23, 2018 | December 2023 |
| NCT00001473 | Completed | Cyclophosphamide and Prednisone Followed by Methotrexate To Treat Vasculitides | March 1995 | March 2004 | |
| NCT00001541 | Completed | Analysis of Bronchial Tissue and Fluid in Patients With Wegener's Granulomatosis | April 1996 | January 2003 | |
| NCT00001761 | Completed | Phase 1 | Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis | February 1998 | April 2000 |
| NCT00001764 | Completed | Phase 1 | Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions | April 1998 | June 2004 |
| NCT00001901 | Completed | Phase 2 | Etanercept to Treat Wegener's Granulomatosis | February 1999 | March 2005 |
| NCT00004357 | Completed | Phase 2 | Absorption of Corticosteroids in Children With Juvenile Dermatomyositis | September 1997 | February 2008 |
| NCT00004567 | Completed | Phase 2 | Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes | February 2000 | June 2004 |
| NCT00005928 | Completed | Phase 2 | Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation | June 2000 | February 2002 |
| NCT00029107 | Completed | Phase 2 | Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis | December 2001 | May 2011 |
| NCT00104299 | Completed | Phase 2/Phase 3 | Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis | January 2005 | January 2010 |
| NCT05984251 | Completed | Phase 1 | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants | December 21, 2009 | April 11, 2011 |
| NCT05604482 | Completed | N/A | CXCR4-PET/CT for Diagnosing Giant Cell Arteritis | October 1, 2021 | September 30, 2023 |
| NCT00301652 | Completed | N/A | MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis | June 2003 | December 2005 |
| NCT00307671 | Completed | Phase 4 | Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years | July 2005 | July 2011 |
| NCT00331331 | Completed | The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease | February 14, 2007 | ||
| NCT00414128 | Completed | Phase 2/Phase 3 | Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis | March 2007 | February 2013 |
| NCT00430755 | Completed | N/A | Improving the Quality of Patient Care by Using a Clinical Expert System. | August 2005 | December 2008 |
| NCT01170936 | Completed | Phase 2 | Ilaris® in Urticarial Vasculitis - Investigation of Treatment Responses | July 2010 | December 2011 |
| NCT01363388 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of CCX168 in Subjects With ANCA-Associated Vasculitis | September 2011 | January 2016 |
| NCT05115370 | Completed | Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 | November 1, 2021 | January 14, 2022 | |
| NCT01663623 | Completed | Phase 3 | Belimumab in Remission of VASculitis | March 20, 2013 | February 6, 2017 |
| NCT01697254 | Completed | The CARRA Registry | August 2009 | October 2015 | |
| NCT01795456 | Completed | Carotid Artery Neovascularization in Takayasu's and Giant Cell Arteritis | August 2010 | January 2014 | |
| NCT01878721 | Completed | Positron Emission Tomography of Infection and Vasculitis | January 2011 | October 2021 | |
| NCT01947465 | Completed | Immunogenicity and Safety of Vaccinations in Immunocompromised Persons | October 2013 | February 2016 | |
| NCT02062346 | Completed | N/A | Endothelin Antagonism in ANCA Vasculitis | August 2016 | January 1, 2020 |
| NCT02084147 | Completed | N/A | PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases | March 7, 2013 | October 2, 2018 |
| NCT02240888 | Completed | N/A | Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response | October 2011 | May 31, 2018 |
| NCT00001155 | Completed | Phase 2 | Treatment of Wegener's Granulomatosis With Cyclophosphamide | February 1976 | February 2002 |
| NCT04554290 | Completed | Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery Biopsy | August 1, 2020 | December 30, 2022 | |
| NCT03941184 | Completed | Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | January 1, 1995 | November 10, 2020 | |
| NCT03804112 | Completed | TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-up | December 17, 2018 | February 18, 2020 | |
| NCT02466217 | Completed | Phenomics in Autoimmune and Inflammatory Diseases | July 29, 2015 | July 18, 2022 | |
| NCT02476292 | Completed | Impact of Vasculitis on Employment and Income | June 2015 | January 2016 | |
| NCT03765424 | Completed | Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell Arteritis | October 1, 2014 | December 31, 2018 | |
| NCT02507024 | Completed | The ANCA Vasculitis Questionnaire (AAV-PRO©) | July 2015 | December 2016 | |
| NCT03410290 | Completed | Journey of Patients With Vasculitis From First Symptom to Diagnosis | January 11, 2018 | May 21, 2018 | |
| NCT00001156 | Completed | Assessment of Patients With Multiple Sclerosis (MS) | January 23, 1976 | February 1, 2010 | |
| NCT00001256 | Completed | Phase 2 | Steroids and Methotrexate to Treat Systemic Vasculitis | March 1990 | February 2004 |
| NCT03371095 | Completed | Phase 3 | Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease | May 25, 2018 | April 11, 2022 |
| NCT03693586 | Completed | Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis | October 19, 2018 | March 8, 2022 | |
| NCT02638701 | Enrolling by invitation | Phase 1/Phase 2 | Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms | July 1, 2018 | December 2026 |
| NCT04629144 | Not yet recruiting | Phase 2 | Multicenter Randomized Double-blind Study Comparing the Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) | March 1, 2021 | March 1, 2025 |
| NCT06321601 | Not yet recruiting | Phase 3 | Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV. | July 31, 2024 | April 28, 2030 |
| NCT03004326 | Recruiting | Clinical Transcriptomics in Systemic Vasculitis (CUTIS) | January 2017 | December 2024 | |
| NCT02280733 | Recruiting | A Real World, Observational Registry of Chronic Wounds and Ulcers | January 2005 | January 2026 | |
| NCT04919538 | Recruiting | Longitudinal Study for Relapsing Polychondritis | February 26, 2021 | January 2026 | |
| NCT05000138 | Recruiting | FDG Digital PET/CT as First Line Investigation for Giant Cell Arteritis | June 10, 2022 | June 30, 2025 | |
| NCT05012033 | Recruiting | Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting | April 12, 2023 | March 26, 2026 | |
| NCT05251415 | Recruiting | Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases | April 4, 2022 | April 4, 2032 | |
| NCT05263817 | Recruiting | Early Phase 1 | A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis | October 8, 2021 | October 1, 2024 |
| NCT05292456 | Recruiting | Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc | February 1, 2021 | December 2022 | |
| NCT05383339 | Recruiting | Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases | November 29, 2022 | November 29, 2031 | |
| NCT05565885 | Recruiting | Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis | November 22, 2022 | December 2037 | |
| NCT05628948 | Recruiting | Vascular Lab Resource (VLR) Biorepository | November 14, 2019 | June 30, 2031 | |
| NCT05635266 | Recruiting | Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | October 26, 2021 | October 2025 | |
| NCT05734404 | Recruiting | Longitudinal Study for Central Nervous System Vasculitis | March 1, 2023 | December 31, 2026 | |
| NCT06065852 | Recruiting | National Registry of Rare Kidney Diseases | November 6, 2009 | December 31, 2039 | |
| NCT02593565 | Recruiting | Vasculitis Pregnancy Registry | November 2015 | December 2026 | |
| NCT02450396 | Recruiting | Pregnancy and Medically Assisted Conception in Rare Diseases | June 2014 | December 2025 | |
| NCT04006535 | Recruiting | Whole Exome Sequencing of Familial and Pediatric Forms of Vasculitis | June 1, 2019 | June 1, 2029 | |
| NCT04294771 | Recruiting | JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors | January 1, 2019 | January 1, 2025 | |
| NCT04413331 | Recruiting | Prospective Longitudinal Cohort Study of Vasculitis Patients | July 2, 2020 | July 2032 | |
| NCT00278512 | Terminated | Phase 1 | Hematopoietic Stem Cell Support in Vasculitis | August 2003 | June 2016 |
| NCT00128895 | Terminated | Phase 4 | Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis | June 2003 | December 2014 |
| NCT03937856 | Terminated | N/A | Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases | May 7, 2019 | April 22, 2021 |
| NCT03692416 | Unknown status | Phase 3 | The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in Children | November 11, 2018 | May 11, 2022 |
| NCT02856243 | Unknown status | Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis | November 2013 | ||
| NCT02498808 | Unknown status | Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases? | September 2015 | December 2018 | |
| NCT02261662 | Unknown status | N/A | Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection | June 2014 | November 2014 |
| NCT03459274 | Unknown status | Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology | March 16, 2018 | June 2018 | |
| NCT04022655 | Unknown status | Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit | July 22, 2019 | October 2019 | |
| NCT05095844 | Unknown status | National Vaccine Adverse Event Reporting Survey and Etiology | March 15, 2022 | April 1, 2024 | |
| NCT01405807 | Unknown status | Phase 4 | Alemtuzumab for ANCA Associated Refractory Vasculitis | February 2011 | March 2014 |
| NCT00103792 | Unknown status | Phase 3 | Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA) | December 2004 | January 2012 |
| NCT02418273 | Withdrawn | Phase 1/Phase 2 | Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders | August 1, 2019 | June 2021 |
- Disase is a (Disease Ontology)
- DOID:178
- Cross Reference ID (Disease Ontology)
- GARD:9565
- Cross Reference ID (Disease Ontology)
- MESH:D014657
- Cross Reference ID (Disease Ontology)
- NCI:C26912
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:195375002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0042384
- Exact Synonym (Disease Ontology)
- Angiitis
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002633
- OrphaNumber from OrphaNet (Orphanet)
- 52759
- MeSH unique ID (MeSH (Medical Subject Headings))
- D014657